MetaCap

Lite Strategy Inc. (LITS)

NASDAQ: LITSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.8026-0.0337 (-4.03%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

LITS stock chart

Technical analysis

Key statistics

All statistics
Market cap
$23.99M
EPS (TTM)
-$1.38
Ex-dividend date
Nov 16, 2023
52-week range
0.69 – 1.99
Day range
0.7901 – 0.865
Volume / Avg
177.44K / 524.33K
Beta
—

52-week range

$0.69$1.99

LITS stock today

Lite Strategy (LITS) closed at $0.8026 on Nov 20, down 4.03% (-$0.0337), versus the S&P 500's 3.70% decline. Trading was light, with 177.44K shares changing hands, about 34% of the average daily volume. At this level, LITS sits near the bottom of its 52-week range of $0.69 to $1.99: 59.7% below the high, set on Nov 26, 2025 and 16.3% above the low.

LITS is down 39.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 52.8%. Lite Strategy has posted a net loss over the last twelve months (EPS of -$1.38), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Lite Strategy

Company profile

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. It is also involved in holding Litecoin tokens as a primary reserve asset.

Industry
Biotechnology: Pharmaceutical Preparations
Headquarters
San Diego, CA
Employees
5
IPO year
2003

Financial highlights

Full financials

Lite Strategy reported a net loss of $71.2 million, compared with a loss of $15.9 million a year earlier. Diluted earnings per share came in at -$2.06.

Lite Strategy annual revenue, net income and EPS
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022
Revenue—$0$65.30M$48.82M$40.70M
Growth—-100.00%+33.76%+19.95%+16.96%
Net income$-71.15M$-15.95M$18.00M$-32.00M$-54.00M
EPS (diluted)$-2.06$-2.39$2.67$-4.78$-9.99

Earnings

Earnings history
Last reported (Sep/2026)
Nov 13, 2026
EPS actual vs est.
$0.48 vs —

Dividends

Dividend history
Annual dividend
$0.00
Last payment
$1.75
Ex-dividend date
Nov 16, 2023

LITS news

All LITS news

Lite Strategy peers

Health Care sector
LITS peer companies
CompanyPrice% ChgMarket capCompare
SCYXSCYNEXIS Inc.2.38-8.64%$23.69Mvs LITS
ABVCABVC BioPharma Inc.0.8663-1.56%$23.37Mvs LITS
IXHLIncannex Healthcare Inc.1.86+6.90%$23.34Mvs LITS
RMTIRockwell Medical Inc.5.82-7.03%$23.12Mvs LITS
IMMPImmutep Limited ADR3.11-9.06%$22.92Mvs LITS
CRVOCervoMed Inc.1.46+9.77%$22.09Mvs LITS
BCTXBriaCell Therapeutics Corp.3.06-3.32%$26.72Mvs LITS
TELOTelomir Pharmaceuticals Inc.0.364-17.24%$26.82Mvs LITS

Indexes, lists and sector

Lite Strategy stock FAQ

What is Lite Strategy's stock price today?

LITS last traded at $0.8026 as of Nov 20, 4:00 PM EST, down 4.03% on the day. Prices are delayed at least 15 minutes.

Does Lite Strategy pay a dividend?

Yes. Lite Strategy pays $0.00 per share annually. The most recent dividend of $1.75 had an ex-dividend date of Nov 16, 2023.

Has LITS ever split its stock?

Yes. The most recent LITS stock split was a 1-for-20 split on Apr 17, 2023, one of 3 splits on record.

What is the LITS 52-week high?

The 52-week high for LITS is $1.99 and the 52-week low is $0.69. The stock is currently 59.7% below its high.

Compare LITS